Bexitrol F
( Salmeterol Xinafoate and Fluticasone Propionate )
Salmeterol Xinafoate is a selective, long acting b2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone Propionate is a corticosteroid with mainly glucocorticoid activity. Fluticasone Propionate is stated to exert a topical effect on the lungs without systemic effects at usual dose. Bexitrol-F combines both ingredients in single inhaler. Bexitrol F is indicated in the regular treatment of asthma where use of a combination product (long acting b2 agonist and inhaled corticosteroid) is appropriate: 1. Patients not adequately controlled with inhaled corticosteroids and with "as needed" inhaled short acting b2 agonist or 2. Patients already adequately controlled on both inhaled corticosteroids and long acting b2 agonist.
- An ideal bronchodilator and corticosteroid combination for total control of asthma
- Ensures anti inflammatory and bronchoprotective action
- Significantly improves pulmonary function in asthma
- Offers improvement in all parameter of asthma
- An ideal choice in the treatment of COPD
- Offers better Pharmacokinetic profile
- Inhalation from single inhaler offers synergistic action
- Offers long term economic benefits
- Ensures compliance & treatment success in asthma
( Salmeterol and Fluticasone Propionate Inhalation Aerosol )
Bexitrol®-F metered dose inhaler is a combination of Salmeterol Xinafoate BP and Fluticasone Propionate BP. Salmeterol Xinafoate is a selective, long acting beta-2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone Propionate is a corticosteroid with mainly glucocorticoid activity. Fluticasone Propionate is stated to exert a topical effect on the lungs without systematic effects at usual dose.
( HFA Inhalation Aerosol Salmeterol and Fluticasone Propionate )
Bexitrol®-F metered dose inhaler is a combination of Salmeterol Xinafoate BP and Fluticasone Propionate BP. Salmeterol Xinafoate is a selective, long acting beta-2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone Propionate is a corticosteroid with mainly glucocorticoid activity. Fluticasone Propionate is stated to exert a topical effect on the lungs without systematic effects at usual dose.